Managing Atopic Dermatitis in Patients With Skin of Color

J Allergy Clin Immunol Pract. 2023 May;11(5):1376-1383. doi: 10.1016/j.jaip.2023.03.041. Epub 2023 Mar 29.

Abstract

Managing atopic dermatitis (AD) in patients with skin of color presents unique challenges for the clinician. There is increasing evidence that AD has higher prevalence, persistence, and severity among skin of color populations. This is likely to be partly related to differences in living conditions and exposure to irritants and allergens, among other factors. Assessment of AD severity in patients with darker skin can be challenging, in particular the assessment of erythema, leading to the potential for underscoring AD severity. Variations in disease have also been described, with the potential for a greater risk of inflammation-induced nodularity and hyper- or hypopigmentation. Management challenges include variable adherence to treatment, potential disparities in access to health care, and differences in the metabolism of cyclosporine. Optimal management of AD in patients with skin of color requires a tailored approach. Here, we review approaches to diagnosing AD, evaluating extent and severity with subjective and objective measures, considering treatment options for patients with skin of color, and highlighting areas for improvement in AD care for skin of color populations.

Keywords: Atopic dermatitis; Diagnosis; Management; Prevalence; Skin of color; Treatment.

Publication types

  • Review

MeSH terms

  • Allergens
  • Dermatitis, Atopic* / diagnosis
  • Dermatitis, Atopic* / epidemiology
  • Dermatitis, Atopic* / therapy
  • Erythema
  • Humans
  • Skin
  • Skin Pigmentation

Substances

  • Allergens